Delivery Order SPE2DB22D9367-SPE2DB24FSZ92

Award Date 9/24/24
Potential Completion Date 10/16/24
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $11,587.21. The award was made by the Defense Logistics Agency (DLA) under the Medical Supply Chain program to provide a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $82,417.09. The contract, awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division, is part of a larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999. This IDC, which runs through December 31, 2025, allows the DLA to issue delivery orders for a comprehensive range of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) to provide a wide range of pharmaceutical products and medical supplies to military health facilities worldwide. The contract, valued at up to $499,999,999, is an indefinite delivery contract (IDC) under the DLA's SPE2DB program that allows for the issuance of firm fixed-price delivery orders for a comprehensive portfolio of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $11,849.81 under a larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) valued at up to $499,999,999. The IDC, which runs through December 31, 2025, allows the DLA to issue firm fixed-price delivery orders to DMS Pharmaceutical Group for a comprehensive range of pharmaceutical items, including both common and...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $18,526.83 under a larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) worth up to $499,999,999. The contract, which runs through December 31, 2025, is for the supply of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The contract covers a wide range of pharmaceutical products, including common medications as well as specialized drugs and medical supplies, to fulfill the recurring medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. The...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities and VA medical centers nationwide. The contract, a $20,858.20 firm fixed-price delivery order, is part of a larger $499,999,999 indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program. This IDC allows the DLA to issue...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $10,747.17 firm fixed-price delivery order is for the supply of pharmaceutical products, including prescription drugs, over-the-counter medications, and medical consumables, to support the recurring medical needs of military health facilities worldwide. The award is part of a larger $499,999,999 indefinite delivery contract...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides the Defense Logistics Agency (DLA) with a wide range of pharmaceutical products and medical supplies. The contract, valued at up to $57,317.20, is a firm fixed-price delivery order with no set-aside designation. The contract covers a comprehensive array of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The contract runs through December 31, 2025 and allows the DLA to issue firm fixed-price delivery orders to DMS Pharmaceutical Group for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health...
  • SPE2DB22D9367
    Indefinite Delivery Contract
  • SPE2DB22D9367-SPE2DB24FSZ92
    Delivery Order

This federal contract award issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, provides for the delivery of pharmaceutical products to support military healthcare facilities worldwide. The contract, valued at up to $20,935.08, is a firm fixed-price delivery order with no set-aside designation.

The award is issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities globally. Through this IDC, DMS Pharmaceutical Group supplies both common medications and specialized drugs and medical supplies to the Department of Defense healthcare system.

Generated 12/24/24, 9:25 AM